nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Imiquimod—skin cancer	0.174	0.224	CbGbCtD
Palonosetron—CYP1A2—Vemurafenib—skin cancer	0.0951	0.123	CbGbCtD
Palonosetron—CYP3A4—Imiquimod—skin cancer	0.0909	0.117	CbGbCtD
Palonosetron—CYP3A4—Temozolomide—skin cancer	0.0909	0.117	CbGbCtD
Palonosetron—CYP2D6—Vemurafenib—skin cancer	0.0784	0.101	CbGbCtD
Palonosetron—CYP1A2—Dacarbazine—skin cancer	0.0729	0.0941	CbGbCtD
Palonosetron—CYP3A4—Vismodegib—skin cancer	0.063	0.0814	CbGbCtD
Palonosetron—CYP3A4—Vemurafenib—skin cancer	0.0498	0.0643	CbGbCtD
Palonosetron—CYP1A2—Fluorouracil—skin cancer	0.0427	0.0552	CbGbCtD
Palonosetron—CYP3A4—Docetaxel—skin cancer	0.0171	0.0221	CbGbCtD
Palonosetron—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000702	0.00311	CcSEcCtD
Palonosetron—Convulsion—Imiquimod—skin cancer	0.000697	0.00309	CcSEcCtD
Palonosetron—Abdominal distension—Temozolomide—skin cancer	0.000697	0.00309	CcSEcCtD
Palonosetron—Fluid retention—Docetaxel—skin cancer	0.000697	0.00309	CcSEcCtD
Palonosetron—Hypertension—Imiquimod—skin cancer	0.000695	0.00308	CcSEcCtD
Palonosetron—Arthralgia—Imiquimod—skin cancer	0.000685	0.00304	CcSEcCtD
Palonosetron—Myalgia—Imiquimod—skin cancer	0.000685	0.00304	CcSEcCtD
Palonosetron—Anxiety—Imiquimod—skin cancer	0.000683	0.00303	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000681	0.00302	CcSEcCtD
Palonosetron—Discomfort—Imiquimod—skin cancer	0.000677	0.003	CcSEcCtD
Palonosetron—Dry mouth—Imiquimod—skin cancer	0.00067	0.00297	CcSEcCtD
Palonosetron—Decreased appetite—Vemurafenib—skin cancer	0.00067	0.00297	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000665	0.00295	CcSEcCtD
Palonosetron—Fatigue—Vemurafenib—skin cancer	0.000664	0.00295	CcSEcCtD
Palonosetron—Constipation—Vemurafenib—skin cancer	0.000659	0.00292	CcSEcCtD
Palonosetron—Infection—Imiquimod—skin cancer	0.000653	0.0029	CcSEcCtD
Palonosetron—Shock—Imiquimod—skin cancer	0.000646	0.00287	CcSEcCtD
Palonosetron—Nervous system disorder—Imiquimod—skin cancer	0.000644	0.00286	CcSEcCtD
Palonosetron—Tachycardia—Imiquimod—skin cancer	0.000641	0.00284	CcSEcCtD
Palonosetron—Skin disorder—Imiquimod—skin cancer	0.000638	0.00283	CcSEcCtD
Palonosetron—Anorexia—Imiquimod—skin cancer	0.000626	0.00278	CcSEcCtD
Palonosetron—Hyperglycaemia—Temozolomide—skin cancer	0.000625	0.00277	CcSEcCtD
Palonosetron—Body temperature increased—Vemurafenib—skin cancer	0.000609	0.0027	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000599	0.00266	CcSEcCtD
Palonosetron—Insomnia—Imiquimod—skin cancer	0.000594	0.00264	CcSEcCtD
Palonosetron—Paraesthesia—Imiquimod—skin cancer	0.00059	0.00262	CcSEcCtD
Palonosetron—Chills—Bleomycin—skin cancer	0.000589	0.00261	CcSEcCtD
Palonosetron—Dyspnoea—Imiquimod—skin cancer	0.000586	0.0026	CcSEcCtD
Palonosetron—Somnolence—Imiquimod—skin cancer	0.000584	0.00259	CcSEcCtD
Palonosetron—Hepatobiliary disease—Temozolomide—skin cancer	0.000584	0.00259	CcSEcCtD
Palonosetron—Alopecia—Bleomycin—skin cancer	0.000581	0.00258	CcSEcCtD
Palonosetron—Sinusitis—Temozolomide—skin cancer	0.000579	0.00257	CcSEcCtD
Palonosetron—Dyspepsia—Imiquimod—skin cancer	0.000578	0.00257	CcSEcCtD
Palonosetron—Erythema—Bleomycin—skin cancer	0.000572	0.00254	CcSEcCtD
Palonosetron—Decreased appetite—Imiquimod—skin cancer	0.000571	0.00253	CcSEcCtD
Palonosetron—Hot flush—Docetaxel—skin cancer	0.000569	0.00253	CcSEcCtD
Palonosetron—Hypersensitivity—Vemurafenib—skin cancer	0.000568	0.00252	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Imiquimod—skin cancer	0.000567	0.00252	CcSEcCtD
Palonosetron—Fatigue—Imiquimod—skin cancer	0.000566	0.00251	CcSEcCtD
Palonosetron—Menopausal symptoms—Docetaxel—skin cancer	0.000565	0.0025	CcSEcCtD
Palonosetron—Pain—Imiquimod—skin cancer	0.000562	0.00249	CcSEcCtD
Palonosetron—Asthenia—Vemurafenib—skin cancer	0.000553	0.00245	CcSEcCtD
Palonosetron—Chills—Dactinomycin—skin cancer	0.00055	0.00244	CcSEcCtD
Palonosetron—Urinary tract disorder—Temozolomide—skin cancer	0.000547	0.00243	CcSEcCtD
Palonosetron—Pruritus—Vemurafenib—skin cancer	0.000545	0.00242	CcSEcCtD
Palonosetron—Connective tissue disorder—Temozolomide—skin cancer	0.000545	0.00242	CcSEcCtD
Palonosetron—Urethral disorder—Temozolomide—skin cancer	0.000543	0.00241	CcSEcCtD
Palonosetron—Alopecia—Dactinomycin—skin cancer	0.000541	0.0024	CcSEcCtD
Palonosetron—Gastrointestinal pain—Imiquimod—skin cancer	0.000537	0.00238	CcSEcCtD
Palonosetron—Epistaxis—Fluorouracil—skin cancer	0.000536	0.00238	CcSEcCtD
Palonosetron—Sinusitis—Fluorouracil—skin cancer	0.000534	0.00237	CcSEcCtD
Palonosetron—Erythema—Dactinomycin—skin cancer	0.000533	0.00237	CcSEcCtD
Palonosetron—Pain in extremity—Docetaxel—skin cancer	0.000533	0.00236	CcSEcCtD
Palonosetron—Anaemia—Bleomycin—skin cancer	0.000529	0.00234	CcSEcCtD
Palonosetron—Diarrhoea—Vemurafenib—skin cancer	0.000527	0.00234	CcSEcCtD
Palonosetron—Abdominal pain—Imiquimod—skin cancer	0.000519	0.0023	CcSEcCtD
Palonosetron—Body temperature increased—Imiquimod—skin cancer	0.000519	0.0023	CcSEcCtD
Palonosetron—Eye disorder—Temozolomide—skin cancer	0.000518	0.0023	CcSEcCtD
Palonosetron—Tinnitus—Temozolomide—skin cancer	0.000517	0.00229	CcSEcCtD
Palonosetron—Cardiac disorder—Temozolomide—skin cancer	0.000514	0.00228	CcSEcCtD
Palonosetron—Dizziness—Vemurafenib—skin cancer	0.000509	0.00226	CcSEcCtD
Palonosetron—Angiopathy—Temozolomide—skin cancer	0.000503	0.00223	CcSEcCtD
Palonosetron—Immune system disorder—Temozolomide—skin cancer	0.000501	0.00222	CcSEcCtD
Palonosetron—Mediastinal disorder—Temozolomide—skin cancer	0.000499	0.00222	CcSEcCtD
Palonosetron—Chills—Temozolomide—skin cancer	0.000497	0.00221	CcSEcCtD
Palonosetron—Anaemia—Dactinomycin—skin cancer	0.000493	0.00219	CcSEcCtD
Palonosetron—Vomiting—Vemurafenib—skin cancer	0.00049	0.00217	CcSEcCtD
Palonosetron—Alopecia—Temozolomide—skin cancer	0.00049	0.00217	CcSEcCtD
Palonosetron—Myalgia—Bleomycin—skin cancer	0.000487	0.00216	CcSEcCtD
Palonosetron—Abdominal pain upper—Docetaxel—skin cancer	0.000487	0.00216	CcSEcCtD
Palonosetron—Rash—Vemurafenib—skin cancer	0.000486	0.00215	CcSEcCtD
Palonosetron—Mental disorder—Temozolomide—skin cancer	0.000486	0.00215	CcSEcCtD
Palonosetron—Dermatitis—Vemurafenib—skin cancer	0.000485	0.00215	CcSEcCtD
Palonosetron—Hypersensitivity—Imiquimod—skin cancer	0.000484	0.00215	CcSEcCtD
Palonosetron—Headache—Vemurafenib—skin cancer	0.000483	0.00214	CcSEcCtD
Palonosetron—Malnutrition—Temozolomide—skin cancer	0.000482	0.00214	CcSEcCtD
Palonosetron—Erythema—Temozolomide—skin cancer	0.000482	0.00214	CcSEcCtD
Palonosetron—Discomfort—Bleomycin—skin cancer	0.000481	0.00213	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00048	0.00213	CcSEcCtD
Palonosetron—Dysgeusia—Temozolomide—skin cancer	0.000472	0.0021	CcSEcCtD
Palonosetron—Asthenia—Imiquimod—skin cancer	0.000471	0.00209	CcSEcCtD
Palonosetron—Anaphylactic shock—Bleomycin—skin cancer	0.000467	0.00207	CcSEcCtD
Palonosetron—Pruritus—Imiquimod—skin cancer	0.000465	0.00206	CcSEcCtD
Palonosetron—Infection—Bleomycin—skin cancer	0.000464	0.00206	CcSEcCtD
Palonosetron—Nausea—Vemurafenib—skin cancer	0.000458	0.00203	CcSEcCtD
Palonosetron—Arrhythmia—Fluorouracil—skin cancer	0.000456	0.00202	CcSEcCtD
Palonosetron—Myalgia—Dactinomycin—skin cancer	0.000454	0.00201	CcSEcCtD
Palonosetron—Alopecia—Fluorouracil—skin cancer	0.000451	0.002	CcSEcCtD
Palonosetron—Diarrhoea—Imiquimod—skin cancer	0.00045	0.00199	CcSEcCtD
Palonosetron—Discomfort—Dactinomycin—skin cancer	0.000449	0.00199	CcSEcCtD
Palonosetron—Anaemia—Temozolomide—skin cancer	0.000446	0.00198	CcSEcCtD
Palonosetron—Anorexia—Bleomycin—skin cancer	0.000445	0.00197	CcSEcCtD
Palonosetron—Erythema—Fluorouracil—skin cancer	0.000444	0.00197	CcSEcCtD
Palonosetron—Hypotension—Bleomycin—skin cancer	0.000436	0.00193	CcSEcCtD
Palonosetron—Dizziness—Imiquimod—skin cancer	0.000434	0.00193	CcSEcCtD
Palonosetron—Infection—Dactinomycin—skin cancer	0.000432	0.00192	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000425	0.00189	CcSEcCtD
Palonosetron—Paraesthesia—Bleomycin—skin cancer	0.000419	0.00186	CcSEcCtD
Palonosetron—Convulsion—Temozolomide—skin cancer	0.000418	0.00185	CcSEcCtD
Palonosetron—Vomiting—Imiquimod—skin cancer	0.000418	0.00185	CcSEcCtD
Palonosetron—Hypertension—Temozolomide—skin cancer	0.000416	0.00185	CcSEcCtD
Palonosetron—Dyspnoea—Bleomycin—skin cancer	0.000416	0.00185	CcSEcCtD
Palonosetron—Anorexia—Dactinomycin—skin cancer	0.000415	0.00184	CcSEcCtD
Palonosetron—Rash—Imiquimod—skin cancer	0.000414	0.00184	CcSEcCtD
Palonosetron—Dermatitis—Imiquimod—skin cancer	0.000414	0.00184	CcSEcCtD
Palonosetron—Headache—Imiquimod—skin cancer	0.000412	0.00183	CcSEcCtD
Palonosetron—Anaemia—Fluorouracil—skin cancer	0.000411	0.00182	CcSEcCtD
Palonosetron—Arthralgia—Temozolomide—skin cancer	0.000411	0.00182	CcSEcCtD
Palonosetron—Myalgia—Temozolomide—skin cancer	0.000411	0.00182	CcSEcCtD
Palonosetron—Anxiety—Temozolomide—skin cancer	0.000409	0.00182	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000408	0.00181	CcSEcCtD
Palonosetron—Discomfort—Temozolomide—skin cancer	0.000406	0.0018	CcSEcCtD
Palonosetron—Decreased appetite—Bleomycin—skin cancer	0.000406	0.0018	CcSEcCtD
Palonosetron—Dry mouth—Temozolomide—skin cancer	0.000402	0.00178	CcSEcCtD
Palonosetron—Pain—Bleomycin—skin cancer	0.000399	0.00177	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000397	0.00176	CcSEcCtD
Palonosetron—Anaphylactic shock—Temozolomide—skin cancer	0.000394	0.00175	CcSEcCtD
Palonosetron—Infection—Temozolomide—skin cancer	0.000391	0.00174	CcSEcCtD
Palonosetron—Nausea—Imiquimod—skin cancer	0.00039	0.00173	CcSEcCtD
Palonosetron—Hepatobiliary disease—Docetaxel—skin cancer	0.000388	0.00172	CcSEcCtD
Palonosetron—Epistaxis—Docetaxel—skin cancer	0.000387	0.00172	CcSEcCtD
Palonosetron—Nervous system disorder—Temozolomide—skin cancer	0.000386	0.00171	CcSEcCtD
Palonosetron—Convulsion—Fluorouracil—skin cancer	0.000385	0.00171	CcSEcCtD
Palonosetron—Skin disorder—Temozolomide—skin cancer	0.000382	0.0017	CcSEcCtD
Palonosetron—Myalgia—Fluorouracil—skin cancer	0.000378	0.00168	CcSEcCtD
Palonosetron—Decreased appetite—Dactinomycin—skin cancer	0.000378	0.00168	CcSEcCtD
Palonosetron—Fatigue—Dactinomycin—skin cancer	0.000375	0.00166	CcSEcCtD
Palonosetron—Anorexia—Temozolomide—skin cancer	0.000375	0.00166	CcSEcCtD
Palonosetron—Discomfort—Fluorouracil—skin cancer	0.000374	0.00166	CcSEcCtD
Palonosetron—Pain—Dactinomycin—skin cancer	0.000372	0.00165	CcSEcCtD
Palonosetron—Body temperature increased—Bleomycin—skin cancer	0.000369	0.00164	CcSEcCtD
Palonosetron—Urinary tract disorder—Docetaxel—skin cancer	0.000364	0.00161	CcSEcCtD
Palonosetron—Anaphylactic shock—Fluorouracil—skin cancer	0.000363	0.00161	CcSEcCtD
Palonosetron—Connective tissue disorder—Docetaxel—skin cancer	0.000362	0.00161	CcSEcCtD
Palonosetron—Urethral disorder—Docetaxel—skin cancer	0.000361	0.0016	CcSEcCtD
Palonosetron—Infection—Fluorouracil—skin cancer	0.00036	0.0016	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000359	0.00159	CcSEcCtD
Palonosetron—Insomnia—Temozolomide—skin cancer	0.000356	0.00158	CcSEcCtD
Palonosetron—Gastrointestinal pain—Dactinomycin—skin cancer	0.000356	0.00158	CcSEcCtD
Palonosetron—Nervous system disorder—Fluorouracil—skin cancer	0.000356	0.00158	CcSEcCtD
Palonosetron—Tachycardia—Fluorouracil—skin cancer	0.000354	0.00157	CcSEcCtD
Palonosetron—Paraesthesia—Temozolomide—skin cancer	0.000354	0.00157	CcSEcCtD
Palonosetron—Dyspnoea—Temozolomide—skin cancer	0.000351	0.00156	CcSEcCtD
Palonosetron—Somnolence—Temozolomide—skin cancer	0.00035	0.00155	CcSEcCtD
Palonosetron—Dyspepsia—Temozolomide—skin cancer	0.000347	0.00154	CcSEcCtD
Palonosetron—Anorexia—Fluorouracil—skin cancer	0.000346	0.00153	CcSEcCtD
Palonosetron—Eye disorder—Docetaxel—skin cancer	0.000344	0.00153	CcSEcCtD
Palonosetron—Body temperature increased—Dactinomycin—skin cancer	0.000344	0.00153	CcSEcCtD
Palonosetron—Abdominal pain—Dactinomycin—skin cancer	0.000344	0.00153	CcSEcCtD
Palonosetron—Hypersensitivity—Bleomycin—skin cancer	0.000344	0.00153	CcSEcCtD
Palonosetron—Decreased appetite—Temozolomide—skin cancer	0.000342	0.00152	CcSEcCtD
Palonosetron—Cardiac disorder—Docetaxel—skin cancer	0.000342	0.00152	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Temozolomide—skin cancer	0.00034	0.00151	CcSEcCtD
Palonosetron—Fatigue—Temozolomide—skin cancer	0.000339	0.00151	CcSEcCtD
Palonosetron—Hypotension—Fluorouracil—skin cancer	0.000339	0.0015	CcSEcCtD
Palonosetron—Pain—Temozolomide—skin cancer	0.000337	0.00149	CcSEcCtD
Palonosetron—Constipation—Temozolomide—skin cancer	0.000337	0.00149	CcSEcCtD
Palonosetron—Asthenia—Bleomycin—skin cancer	0.000335	0.00149	CcSEcCtD
Palonosetron—Angiopathy—Docetaxel—skin cancer	0.000334	0.00148	CcSEcCtD
Palonosetron—Immune system disorder—Docetaxel—skin cancer	0.000333	0.00148	CcSEcCtD
Palonosetron—Mediastinal disorder—Docetaxel—skin cancer	0.000332	0.00147	CcSEcCtD
Palonosetron—Chills—Docetaxel—skin cancer	0.000331	0.00147	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00033	0.00147	CcSEcCtD
Palonosetron—Pruritus—Bleomycin—skin cancer	0.00033	0.00146	CcSEcCtD
Palonosetron—Arrhythmia—Docetaxel—skin cancer	0.000329	0.00146	CcSEcCtD
Palonosetron—Insomnia—Fluorouracil—skin cancer	0.000328	0.00146	CcSEcCtD
Palonosetron—Paraesthesia—Fluorouracil—skin cancer	0.000326	0.00144	CcSEcCtD
Palonosetron—Alopecia—Docetaxel—skin cancer	0.000326	0.00144	CcSEcCtD
Palonosetron—Dyspnoea—Fluorouracil—skin cancer	0.000323	0.00143	CcSEcCtD
Palonosetron—Mental disorder—Docetaxel—skin cancer	0.000323	0.00143	CcSEcCtD
Palonosetron—Somnolence—Fluorouracil—skin cancer	0.000322	0.00143	CcSEcCtD
Palonosetron—Gastrointestinal pain—Temozolomide—skin cancer	0.000322	0.00143	CcSEcCtD
Palonosetron—Malnutrition—Docetaxel—skin cancer	0.000321	0.00142	CcSEcCtD
Palonosetron—Erythema—Docetaxel—skin cancer	0.000321	0.00142	CcSEcCtD
Palonosetron—Hypersensitivity—Dactinomycin—skin cancer	0.000321	0.00142	CcSEcCtD
Palonosetron—Dyspepsia—Fluorouracil—skin cancer	0.000319	0.00142	CcSEcCtD
Palonosetron—Decreased appetite—Fluorouracil—skin cancer	0.000315	0.0014	CcSEcCtD
Palonosetron—Dysgeusia—Docetaxel—skin cancer	0.000314	0.00139	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000313	0.00139	CcSEcCtD
Palonosetron—Asthenia—Dactinomycin—skin cancer	0.000312	0.00139	CcSEcCtD
Palonosetron—Body temperature increased—Temozolomide—skin cancer	0.000311	0.00138	CcSEcCtD
Palonosetron—Abdominal pain—Temozolomide—skin cancer	0.000311	0.00138	CcSEcCtD
Palonosetron—Pain—Fluorouracil—skin cancer	0.00031	0.00138	CcSEcCtD
Palonosetron—Diarrhoea—Dactinomycin—skin cancer	0.000298	0.00132	CcSEcCtD
Palonosetron—Vomiting—Bleomycin—skin cancer	0.000297	0.00132	CcSEcCtD
Palonosetron—Anaemia—Docetaxel—skin cancer	0.000297	0.00132	CcSEcCtD
Palonosetron—Rash—Bleomycin—skin cancer	0.000294	0.00131	CcSEcCtD
Palonosetron—Dermatitis—Bleomycin—skin cancer	0.000294	0.0013	CcSEcCtD
Palonosetron—Hypersensitivity—Temozolomide—skin cancer	0.00029	0.00129	CcSEcCtD
Palonosetron—Body temperature increased—Fluorouracil—skin cancer	0.000287	0.00127	CcSEcCtD
Palonosetron—Asthenia—Temozolomide—skin cancer	0.000282	0.00125	CcSEcCtD
Palonosetron—Pruritus—Temozolomide—skin cancer	0.000279	0.00124	CcSEcCtD
Palonosetron—Convulsion—Docetaxel—skin cancer	0.000278	0.00123	CcSEcCtD
Palonosetron—Nausea—Bleomycin—skin cancer	0.000277	0.00123	CcSEcCtD
Palonosetron—Hypertension—Docetaxel—skin cancer	0.000277	0.00123	CcSEcCtD
Palonosetron—Vomiting—Dactinomycin—skin cancer	0.000277	0.00123	CcSEcCtD
Palonosetron—Rash—Dactinomycin—skin cancer	0.000274	0.00122	CcSEcCtD
Palonosetron—Myalgia—Docetaxel—skin cancer	0.000273	0.00121	CcSEcCtD
Palonosetron—Arthralgia—Docetaxel—skin cancer	0.000273	0.00121	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000271	0.0012	CcSEcCtD
Palonosetron—Diarrhoea—Temozolomide—skin cancer	0.000269	0.00119	CcSEcCtD
Palonosetron—Hypersensitivity—Fluorouracil—skin cancer	0.000267	0.00119	CcSEcCtD
Palonosetron—Dry mouth—Docetaxel—skin cancer	0.000267	0.00118	CcSEcCtD
Palonosetron—Anaphylactic shock—Docetaxel—skin cancer	0.000262	0.00116	CcSEcCtD
Palonosetron—Dizziness—Temozolomide—skin cancer	0.00026	0.00115	CcSEcCtD
Palonosetron—Infection—Docetaxel—skin cancer	0.00026	0.00115	CcSEcCtD
Palonosetron—Nausea—Dactinomycin—skin cancer	0.000259	0.00115	CcSEcCtD
Palonosetron—Shock—Docetaxel—skin cancer	0.000258	0.00114	CcSEcCtD
Palonosetron—Nervous system disorder—Docetaxel—skin cancer	0.000257	0.00114	CcSEcCtD
Palonosetron—Pruritus—Fluorouracil—skin cancer	0.000257	0.00114	CcSEcCtD
Palonosetron—Tachycardia—Docetaxel—skin cancer	0.000256	0.00113	CcSEcCtD
Palonosetron—Skin disorder—Docetaxel—skin cancer	0.000254	0.00113	CcSEcCtD
Palonosetron—Vomiting—Temozolomide—skin cancer	0.00025	0.00111	CcSEcCtD
Palonosetron—Anorexia—Docetaxel—skin cancer	0.00025	0.00111	CcSEcCtD
Palonosetron—Rash—Temozolomide—skin cancer	0.000248	0.0011	CcSEcCtD
Palonosetron—Diarrhoea—Fluorouracil—skin cancer	0.000248	0.0011	CcSEcCtD
Palonosetron—Dermatitis—Temozolomide—skin cancer	0.000248	0.0011	CcSEcCtD
Palonosetron—Headache—Temozolomide—skin cancer	0.000247	0.00109	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—skin cancer	0.000245	0.00109	CcSEcCtD
Palonosetron—Dizziness—Fluorouracil—skin cancer	0.00024	0.00106	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000239	0.00106	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—skin cancer	0.000237	0.00105	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—skin cancer	0.000235	0.00104	CcSEcCtD
Palonosetron—Nausea—Temozolomide—skin cancer	0.000234	0.00104	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—skin cancer	0.000233	0.00104	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—skin cancer	0.000233	0.00103	CcSEcCtD
Palonosetron—Vomiting—Fluorouracil—skin cancer	0.000231	0.00102	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—skin cancer	0.00023	0.00102	CcSEcCtD
Palonosetron—Rash—Fluorouracil—skin cancer	0.000229	0.00101	CcSEcCtD
Palonosetron—Dermatitis—Fluorouracil—skin cancer	0.000229	0.00101	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—skin cancer	0.000228	0.00101	CcSEcCtD
Palonosetron—Headache—Fluorouracil—skin cancer	0.000227	0.00101	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—skin cancer	0.000226	0.001	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—skin cancer	0.000226	0.001	CcSEcCtD
Palonosetron—Pain—Docetaxel—skin cancer	0.000224	0.000993	CcSEcCtD
Palonosetron—Constipation—Docetaxel—skin cancer	0.000224	0.000993	CcSEcCtD
Palonosetron—Nausea—Fluorouracil—skin cancer	0.000215	0.000956	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—skin cancer	0.000214	0.00095	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—skin cancer	0.000207	0.000918	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—skin cancer	0.000207	0.000918	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—skin cancer	0.000193	0.000856	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—skin cancer	0.000188	0.000833	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—skin cancer	0.000185	0.000822	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—skin cancer	0.000179	0.000795	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—skin cancer	0.000173	0.000768	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—skin cancer	0.000166	0.000738	CcSEcCtD
Palonosetron—Rash—Docetaxel—skin cancer	0.000165	0.000732	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—skin cancer	0.000165	0.000732	CcSEcCtD
Palonosetron—Headache—Docetaxel—skin cancer	0.000164	0.000728	CcSEcCtD
Palonosetron—Nausea—Docetaxel—skin cancer	0.000156	0.00069	CcSEcCtD
